QQ客服 官方微博 反馈留言

	Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction
	Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven
刊名	Journal of Clinical Oncology
	2013
卷号	31
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4896632
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven. Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction[J]. Journal of Clinical Oncology,2013,31.
APA	Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven.(2013).Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction.Journal of Clinical Oncology,31.
MLA	Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven."Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction".Journal of Clinical Oncology 31(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。